Table of Contents
About one in every 1,000 adults in the United States develops a deep vein thrombosis each year, and roughly half of those clots appear without an obvious trigger such as surgery, a cast or a twelve-hour flight. A fair share of those unexplained cases trace back to a clotting disorder, the group of conditions doctors call thrombophilias.
Plenty of people carry one and never find out. Others meet the diagnosis in an emergency department, usually with a swollen calf or a sudden shortness of breath that turns out to be a pulmonary embolism. If you are trying to make sense of a diagnosis, or of a relative’s, here are the seven clotting disorders you are most likely to come across, what each one does to the blood, and how much it really matters. For a wider view of how these sit alongside other conditions, this rundown of the most common blood disorders and their warning signs is a useful starting point.
What a clotting disorder actually is
Clotting is a chain reaction involving a dozen or so proteins, most of them made in the liver. Each step switches on the next until fibrin strands lock together and seal a wound. The body also builds brakes into that chain, proteins that switch the reaction off once the job is done. A clotting disorder means the accelerator is stuck slightly on, or a brake is weak, so clots form when they are not needed.
Inherited forms are written into your DNA and present from birth. Acquired forms come from something else going on: an immune system that has turned against its own phospholipids, liver disease that leaves clotting proteins out of balance, or a heart that pumps poorly, as in cardiomyopathy, letting blood pool and clot inside the chambers. Having a thrombophilia does not mean you will clot. It means your odds are higher than average, and other factors decide whether that risk ever becomes a real event.
1. Factor V Leiden
This is the most common inherited clotting disorder in people of European descent, carried by roughly 1 in 20. Factor V is a protein that helps build the clot; activated protein C normally switches it off. The Leiden mutation changes the protein so that protein C can no longer cut it, a phenomenon called activated protein C resistance.
One copy raises clot risk about three to eight times. Two copies, which is rare, can push it fifty-fold or more. Many carriers go their whole lives without a clot, and the ones who do often have a second trigger in the picture: combined oral contraceptives, pregnancy, smoking, a long-haul flight, or a broken leg in plaster.
2. Prothrombin gene mutation (G20210A)
Found in about 2% of people with European ancestry, this variant turns up the volume on prothrombin, also known as factor II. More prothrombin means more thrombin, and more thrombin means more fibrin. The risk is modest on its own, roughly two to three times baseline, but it frequently appears alongside Factor V Leiden in the same family, and the combination is stronger than either alone.
3. Protein C deficiency
Protein C is one of the body’s natural anticoagulants, a genuine brake on the clotting cascade. About 1 in 200 to 1 in 500 people have less of it than they should. Heterozygotes face roughly a seven- to ten-fold increase in clot risk, often in the veins of the legs, and sometimes in unusual sites such as the cerebral veins.
There is a clinical quirk worth knowing: starting warfarin in someone with undiagnosed protein C deficiency can trigger warfarin-induced skin necrosis, because warfarin drops protein C faster than it drops the clotting factors. That is why doctors bridge with heparin first. The severe homozygous form is rare and shows up in newborns as purpura fulminans.
4. Protein S deficiency
Protein S works as protein C’s assistant, helping it dock onto cell membranes. Levels run in families the same way protein C deficiency does, affecting roughly 1 in 500 people, with a similar clot risk. The tricky part is testing. Protein S drops naturally during pregnancy and while on oestrogen, and falls with liver disease or vitamin K deficiency, so one low reading proves very little. Doctors usually repeat the test weeks later, away from a clot and off blood thinners.
5. Antithrombin deficiency
Antithrombin shuts down thrombin and factor Xa directly. When it is low, clots tend to arrive earlier, often in someone’s twenties or thirties, and recur more often than with the milder thrombophilias. Depending on the population studied, prevalence runs from 1 in 500 to 1 in 5,000.
It has a practical consequence in hospital. People with antithrombin deficiency can be resistant to standard heparin doses, which matters during surgery, dialysis or a stay in intensive care. If you know you have it, tell every clinician who prescribes heparin for you.
6. Antiphospholipid syndrome
This one is acquired, not inherited, and driven by the immune system producing antibodies against phospholipids, the fat molecules that stud cell membranes. The result is paradoxical: clotting in veins and arteries, plus pregnancy complications such as recurrent early loss or second-trimester loss. It accounts for a meaningful slice of strokes in adults under 50.
Diagnosis needs more than a single blood test. Guidelines require a positive antibody result on two occasions at least twelve weeks apart, because transient antibodies show up after infections and mean nothing long term. Because the root cause is immune, some people also notice the broader pattern described in these symptoms of immune system disorders. Treatment usually means long-term anticoagulation, sometimes with aspirin added.
7. Elevated factor VIII
No mutation required here, just a high level. Factor VIII above roughly 150 IU/dL is present in about 11% of the general population and in a much larger share of people who have had an unprovoked clot. It behaves like a persistent risk factor rather than a one-off: studies show high levels predict recurrence after anticoagulation stops.
The catch is that factor VIII rises with inflammation, stress and pregnancy, and it is an acute phase reactant, so a level drawn during a clot or an infection tells you little. It needs checking at least six weeks after the event, when the body has settled.
The signs that justify a same-day call
Clotting disorders are quiet until a clot forms. These are the symptoms that should get you seen promptly rather than at the end of the week:
- Swelling in one leg or calf, often with warmth, redness or a cramping ache that worsens when you stand
- Sudden breathlessness, chest pain that sharpens on a deep breath, coughing up blood, or fainting
- Swelling in one arm, particularly with a central line or after heavy overhead exertion
- Sudden severe headache, speech trouble, facial droop or weakness on one side
- Repeated miscarriages, especially in the second trimester, or a placental complication in pregnancy
- A clot before age 50 with no clear trigger, or a first-degree relative with an unprovoked clot
Stroke deserves a separate note. Not every stroke comes from a clotting disorder. An irregular heartbeat such as atrial fibrillation throws clots out of the heart and is one of the leading causes of stroke, while structural issues such as mitral valve prolapse often surface when doctors are hunting for a cause in a younger patient.
How the testing works
Timing matters more than most people expect. Protein C, protein S and antithrombin all fall during an acute clot and are distorted by warfarin, heparin and direct oral anticoagulants, so results drawn in the middle of an event are close to useless. Genetic tests for Factor V Leiden and the prothrombin mutation do not change over time and can be run whenever a sample is available. Antiphospholipid antibodies need the twelve-week repeat. Anyone doing a full panel should also know that testing is only worth it when the answer will change a decision about treatment duration or pregnancy planning.
Living with a diagnosed clotting disorder
Most of the practical work after diagnosis is about context. A clot provoked by surgery or immobility usually means three months of anticoagulation and then stopping. An unprovoked clot, or one in someone with a high-risk deficiency such as antithrombin, often means treatment continues beyond that, with the risk of bleeding weighed against the risk of another clot.
Oestrogen matters enormously. Combined oral contraceptives multiply clot risk several times over in carriers of Factor V Leiden, and a progestin-only pill or a non-hormonal method is usually the safer conversation to have. Pregnancy needs planning rather than reacting, since low-molecular-weight heparin is the standard choice and it is stopped before delivery. Long journeys over four hours are worth preparing for with hydration, aisle seats and a walk every hour or so, plus compression stockings if a clinician recommends them.
Family testing is the other piece. When someone is found to carry Factor V Leiden, the prothrombin mutation or an antithrombin deficiency, first-degree relatives can be tested once and then stop worrying about it either way. A negative result closes the question for life. A positive one turns a vague family history into something concrete that any doctor treating you can act on.
